More Upside for Bristol-Myers Squibb ? TradersHuddle.com The Company offers products and experimental therapies to address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Bristol-Myers Squibb is currently trading 0.85% versus ... |
